Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)

OBJECTIVE: To determine whether the effect of neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin (MVAC) on the survival of patients with locally advanced urothelial carcinoma (UC) of the bladder treated with radical cystectomy varies with the presence of non-urothelia...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Scosyrev, E., Ely, B.W., Messing, E.M., Speights, V.O., Grossman, H. B., Wood, D.P., de Vere White, R.W., Vogelzang, N.J., Trump, D.L., Natale, R.B., Tangen, C., Crawford, E.D., Thompson, I.M.
Format: Artigo
Langue:Inglês
Publié: 2010
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117124/
https://ncbi.nlm.nih.gov/pubmed/21105991
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1464-410X.2010.09900.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires